Ticking Off Investors, Akari CEO Exits Amid Coversin Trial Controversy

 
• By Sten Stovall
  
Tick
Message From Investors To Akari: Don't Bite The Hand That Feeds You !! • Source: Shutterstock

More from Clinical Trials

More from R&D